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Clostridioides difficile infection (CDI) is a leading cause of antibiotic-associated diarrhoea.
Adhesion of this Gram-positive pathogen to the intestinal epithelium is a crucial step in CDI,
with recurrence and relapse of disease dependent on epithelial interaction of its
endospores. Close proximity, or adhesion of, hypervirulent strains to the intestinal
mucosa are also likely to be necessary for the release of C. difficile toxins, which when
internalized, result in intestinal epithelial cell rounding, damage, inflammation, loss of barrier
function and diarrhoea. Interrupting these C. difficile-epithelium interactions could
therefore represent a promising therapeutic strategy to prevent and treat CDI. Intake of
dietary fibre is widely recognised as being beneficial for intestinal health, and we have
previously shown that soluble non-starch polysaccharides (NSP) from plantain banana
(Musa spp.), can block epithelial adhesion and invasion of a number of gut pathogens,
such as E. coli and Salmonellae. Here, we assessed the action of plantain NSP, and a
range of alternative soluble plant fibres, for inhibitory action on epithelial interactions of C.
difficile clinical isolates, purified endospore preparations and toxins. We found that plantain
NSP possessed ability to disrupt epithelial adhesion of C. difficile vegetative cells and
spores, with inhibitory activity against C. difficile found within the acidic (pectin-rich)
polysaccharide component, through interaction with the intestinal epithelium. Similar
activity was found with NSP purified from broccoli and leek, although seen to be less
potent than NSP from plantain. Whilst plantain NSP could not block the interaction and
intracellular action of purified C. difficile toxins, it significantly diminished the epithelial
impact of C. difficile, reducing both bacteria and toxin induced inflammation, activation of
caspase 3/7 and cytotoxicity in human intestinal cell-line and murine intestinal organoid
cultures. Dietary supplementation with soluble NSP from plantain may therefore confer a
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protective effect in CDI patients by preventing adhesion of C. difficile to the mucosa, i.e. a
“contrabiotic” effect, and diminishing its epithelial impact. This suggests that plantain
soluble dietary fibre may be a therapeutically effective nutritional product for use in the
prevention or treatment of CDI and antibiotic-associated diarrhoea.
Keywords: Clostridioides difficile, spores, toxin, intestine, epithelium, soluble dietary fibre
1 INTRODUCTION
Clostridioides difficile is a highly infectious, Gram-positive, spore-
forming anaerobe (Bartlett, 2010) that is recognised as the leading
cause of antibiotic-associated diarrhoea, attributing 15–25% of all
cases (Ananthakrishnan, 2011). C. difficile infection (CDI) causes
a spectrum of intestinal disease, with symptoms ranging from
mild diarrhoea to severe pseudomembranous colitis (PMC),
bowel perforation and toxic megacolon, which can ultimately
be fatal (Rupnik et al., 2009).
Adhesion of C. difficile to the intestinal epithelium represents
an initial and crucial step in the pathogenesis of CDI (Janoir,
2016). To mediate this process, C. difficile possesses adhesins
which exhibit carbohydrate-binding (lectin) activity. These
surface adhesins recognise and bind to complementary
carbohydrates on the surface of host cells, promoting
bacterial-epithelial adherence (Sharon, 2006). Indeed, close
proximity or adhesion of C. difficile to the intestinal mucosa is
also likely to be necessary for the release of C. difficile toxins;
single-chain A and B toxins (TcdA and TcdB) and the binary
toxin (C. difficile transferase; CDT). It is well established that
following their internalisation into cells, via clathrin-mediated
endocytosis (Papatheodorou et al., 2010), C. difficile TcdA and
TcdB are involved in mono-glucosylation of small Rho family
GTPases (Rho, Rac1 and Cdc42), preventing their interaction
with downstream regulators (Just et al., 1995a; Just et al., 1995b;
Sehr et al., 1998). This results in their subsequent inactivation,
leading to increased cell rounding, loss of actin stress fibres and
disruption of intercellular tight junctions (Voth and Ballard,
2005). Other cellular effects of both TcdA and TcdB, include
the induction of an inflammatory response, mediated via
activation of nuclear factor kappa B (NF-κB) and subsequent
release of the key pro-inflammatory cytokines, such as interleukin
8 (IL-8) and interleukin 1 beta (IL-1β) (Kim et al., 2006;
Cowardin et al., 2016). TcdA and TcdB are also known to
mediate programmed cell death through the activation of both
intrinsic and extrinsic apoptotic pathways, and subsequent
activation of executioner caspase-3 (Gerhard et al., 2008). C.
difficile CDT is associated with hypervirulent strains, that may
increase CDI severity and are linked to higher rates of fatal illness
(Bacci et al., 2011; Cowardin et al., 2016; Berry et al., 2017; López-
Cárdenas et al., 2021).
CDT is part of the family of ADP-ribosylating toxins that
when cleaved binds to a lipolysis stimulated lipoprotein receptor
(LSR) on the apical surface of intestinal epithelial cells (Gerding
et al., 2014). The binary toxin itself consists of two unlinked
polypeptides, enzymatic component CDTa and transporter
component CDTb. CDTa is a mono ADP-ribosyl transferase
which becomes internalised into the host, most likely via a CDTb
heptamer on the cell surface. The internalised complex then
translocates via receptor-mediated endocytosis to acidic
endosomes where CDTb, following a decrease of the
endosomal pH, creates a pore in the membrane allowing
translocation of CDTa into the cytosol. There CDTa acts to
irreversibly ADP-ribosylate monomeric G-actin which leads to
inhibition of polymerisation to F-actin, thus disrupting the actin
cytoskeleton resulting in cell rounding and cell death (Carman
et al., 2011; Davies et al., 2011; Beer et al., 2018). Studies have also
suggested that CDT may increase bacterial adherence to target
cells through the formation of microtubule protrusions (Schwan
et al., 2009; Abt et al., 2016). C. difficile toxins also display lectin
activity, binding to specific carbohydrate moieties on the
epithelial cell surface to facilitate their uptake via receptor-
mediated endocytosis. Studies have demonstrated the direct
binding of C. difficile TcdA to glycans expressing the
disaccharide Galβ1-4GlcNAc (Tucker and Wilkins, 1991;
Greco et al., 2006).
In recent years, the incidence of CDI has rapidly increased,
and the disease is becoming associated with higher rates of
morbidity and mortality (Rupnik et al., 2009; Freeman et al.,
2010). A number of hypervirulent C. difficile variants have also
emerged, of most note, the BI/NAP1/027 hypervirulent strain
(Rupnik et al., 2009; O’Connor et al., 2009), shown to secrete
elevated levels of both TcdA and TcdB (Loo et al., 2005;
McDonald et al., 2005). In addition, there has been
considerable increase in recurrence and relapse rates associated
with CDI (Kelly, 2012), due to the ability to produce endospores
(Burns et al., 2011). This robust, dormant form of C. difficile can
survive almost indefinitely outside the host, and persists on
clinical surfaces for long periods of time (Burns et al., 2011).
Once ingested by a susceptible individual, spores return to
vegetative growth through germination, resulting in
colonisation, toxin release and subsequent active disease
(Burns et al., 2011). It has also been demonstrated that C.
difficile spores are a key vehicle of transmission in CDI,
interacting with the intestinal epithelium (Paredes-Sabja and
Sarker, 2012) and mucosal macrophages (Paredes-Sabja et al.,
2012), leading to persistence within the intestinal tract.
It is clear that C. difficile bacterium, toxin and spore
interaction with the intestinal epithelium all play a key role in
the pathogenesis of CDI. Interrupting these bacteria-epithelial
interactions could therefore represent a promising therapeutic
strategy to prevent and treat CDI. Our own recent studies have
demonstrated that soluble dietary plant non-starch
polysaccharides (NSP), particularly their acidic (pectin-rich)
components, from plantain bananas (Musa spp.), can block
epithelial adhesion of a number of other gut pathogens
(including Salmonella enterica serovar Typhimurium, Shigella
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sonnei and various Escherichia coli pathovars) to human
intestinal epithelial cell-lines in vitro (Martin et al., 2004;
Roberts et al., 2010; Roberts et al., 2013), and also block
bacterial translocation across ex vivo human ileal explants of
villous or follicle-associated epithelium (FAE) (Roberts et al.,
2010; Roberts et al., 2013). The effect is mediated by interaction
between the plantain pectin-rich NSP and the gut epithelial cells.
Efficacy was confirmed in vivo in chickens, where
supplementation of a commercial diet with plantain NSP was
shown to block Salmonella colonisation (Parsons et al., 2014;
Parsons et al., 2015). The purpose of the present study was to
assess the action of plantain NSP on a range of C. difficile clinical
isolates of differing PCR ribotype and toxin status, as well as
testing a range of alternative soluble plant fibres for their
inhibitory action on epithelial interactions of C. difficile.
Plantain NSP was also tested for its ability to inhibit epithelial
adhesion of C. difficile endospores, and on the cellular
interactions of purified C. difficile toxins.
2 MATERIALS AND METHODS
2.1 Human Intestinal Epithelial Cell Cultures
The human colon adenocarcinoma cell-lines Caco-2 (ECACC
#86010202), SW620 (ECACC #87051203) and SW480 (ECACC
#87092801) were obtained from the European Collection of
Authenticated Cell Cultures (Public Health Laboratory Service;
Wiltshire, United Kingdom). Intestine-407 cells (ATCC #CCL-6)
were obtained from the American Type Culture Collection (LGC
Standards: Teddington, United Kingdom). All cell-lines were
initially grown in T-75 tissue culture flasks until 80%
confluent. Cells were trypsinized, and re-seeded at 1 × 105
cells/well to 24-well tissue culture plates (Corning Costar,
High Wycombe, United Kingdom) for infection assays. For
luminescence assays, cells were seeded at 9 × 104 per well in
96-well white bottom culture plates (Costar). Parallel cultures in
96-well clear bottom plates were used to assess confluency by light
microscopy. All cell-lines were cultured in complete Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 10% v/v
foetal bovine serum (Invitrogen; Paisley, United Kingdom),
100 U/ml penicillin, 100 μg/ml streptomycin and 8 mM
glutamine (Sigma Aldrich; Poole, United Kingdom), and
maintained at 37°C in a humidified atmosphere of 5% CO2/
95% air for 24–48 h.
2.2 Murine Intestinal Organoid Cultures
Intestinal organoids were utilised to assess epithelial cytotoxicity
in response to C. difficile purified toxins, as per (Jones et al., 2019).
Mice (C57BL/6J strain, at 10-weeks old) purchased from Charles
River Ltd. (Margate, United Kingdom) and were maintained for
2 weeks prior to tissue harvesting on a standard CRM pelleted
rodent chow diet (Special Diet Services; Witham,
United Kingdom) with water available ad libitum, in a
specific-pathogen-free environment at the Biomedical Services
Unit (University of Liverpool). Mice were sacrificed, under
Schedule 1 of the Animals (Scientific Procedures) Act 1986, by
rising CO2 levels, followed with cervical dislocation. Small
intestine was dissected and transported on ice in sterile
phosphate-buffered saline (PBS) pH 7.3, for use in establishing
organoid cultures over 6 days, as previously described (Jones
et al., 2019). On day 7, cultures were passaged by
mechanically disruption through a 27G needle, resuspended in
fresh Matrigel and plated out again to 24-well plates.
Experimental treatment of organoids was only performed
following a minimum of 1 passage.
2.3 Plant Soluble Non-Starch
Polysaccharides
Plantain (Musa x paradisiaca L.) non-starch polysaccharide
(NSP) preparations from excipient-free plantain flour
(Trobana Green Plantain flour AAB group (Horn)); Confoco
International Ltd.; Ripley, United Kingdom) were prepared by
Provexis plc (Reading, United Kingdom) at the Teagasc Food
Research Centre (Moorepark, Ireland) as previously described
(Roberts et al., 2010; Roberts et al., 2013). A range of other NSP
were also prepared, selected to include representatives of dicots,
commelinoid monocots and non-commelinoid monocots. This
selection ensured a wide variety of NSP composition. The plants
selected included those from the families Rosaceae—apple, pear
and strawberry (dicots); Ericaceae—blueberry (dicot);
Musaceae—plantain (green) (commelinoid monocot);
Solanaceae—tomato and bell pepper (dicots); Poaceae—oat
(commelinoid monocot); Fabaceae—runner bean (dicot);
Brassicaceae—broccoli (dicot); Apiaceae—celery (dicot); and
Amaryllidaceae—leek (non-commelinoid monocot). All were
prepared to the same specification (Provexis plc); see
Supplementary Table S1. Soluble NSP concentrations tested
were within the range of effective luminal concentrations in
the human distal colon that would be readily achievable with
dietary supplementation (Roberts et al., 2010). Neutral and acidic
polysaccharide fractions of soluble NSP from plantain were
prepared by Q-Sepharose anion-exchange chromatography, as
per (Parsons et al., 2014).
2.4 Clostridioides difficile Strains and
Growth Conditions
The laboratory C. difficile reference strain 1470 (ATCC #43598)
was obtained from the American Tissue Type Collection (LGC
Standard; Teddington, United Kingdom). C. difficile clinical
laboratory isolate 080042 (PCR ribotype 027) used in initial
intestinal epithelial cell interaction assays was obtained from
Dr Godfrey Smith (Department of Medical Microbiology,
Royal Liverpool and Broadgreen University Hospitals NHS
Trust, United Kingdom). C. difficile 1342, a pathogenicity
locus (PaLoc) negative strain, was provided by Drs Gillian
Douce and Anthony Buckley (Institute of Infection, Immunity
and Inflammation, University of Glasgow, United Kingdom), a
strain having been originally obtained from Dr Kate Dingle
(Oxford University, Oxford, United Kingdom) (Stoesser et al.,
2011). Eleven additional C. difficile clinical isolates of differing
toxin status and PCR ribotype, and from various geographical
locations, were also obtained from the Royal Liverpool and
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Broadgreen University Hospitals NHS Trust; see Table 1. All
isolates were initially grown in the laboratory under anaerobic
conditions, at 37°C for 48 h, on Brain Heart Infusion (BHIS) agar
supplemented with 0.1% w/v L-cysteine and 5 mg/ml yeast
extract. Prior to infection of cultured intestinal epithelial cells,
C. difficile strains were grown on Fastidious anaerobic agar
(Oxoid), washed three times in sterile PBS pH 7.3, and
resuspended to an OD550nm, equivalent to 1 × 109 CFU/ml.
2.5 Spore Isolation and Purification
Spores from five selected C. difficile clinical isolates (98011,
108536, 108906, 98220, and 1342) were prepared according to
methods previously described (Permpoonpattana et al., 2011),
with some modifications. Briefly, for each isolate, a single
bacterial colony was selected from BHIS agar anaerobic
culture (at 37°C for 48 h) and used to inoculate 10 ml TGY
broth (3% w/v tryptic soy broth, 2% w/v glucose, 1% w/v yeast
extract, 0.1% w/v L-cysteine) After overnight incubation in static
conditions, TGY culture medium was sub-cultured (1:100) into
Sorbitol MacConkey (SMC) broth (9% w/v/peptone, 0.05% w/v
proteose-peptone, 0.1% w/v (NH4)2SO4, 0.15% w/v/Tris, 0.1%
w/v L-cysteine) and incubated at 37°C to an OD600nm  0.5.
Aliquots of culture broth were used to inoculate a dozen SMC
agar plates per strain, which were incubated under anaerobic
conditions, at 37°C for 10 days. After day 10, spores were
harvested and washed twice with sterile water, then suspended
in 2 ml sterile PBS pH 7.3 containing 125 mM Tris, 200 mM
EDTA, 0.3 mg/ml proteinase K and 1% v/v sarcosyl, and
incubated at 37°C for 2 h with gentle shaking. Spores were
then centrifuged (4,500 x g for 20 min) and the pellet
resuspended in cold sterile distilled water. This was repeated a
further 10 times. After the final wash, spores were heat-treated
(60°C, for 20 min) to kill any residual vegetative cells, and then
frozen at −20°C until use. To calculate spore numbers, aliquots
were serially diluted in sterile PBS and plated onto BHIS agar
supplemented with 0.1% w/v sodium taurocholate for spore
germination (Sorg and Sonenshein, 2008; Burns and Minton,
2011). After 48 h, spore titres were enumerated by enumerating
vegetative bacteria colony forming units (CFU). To confirm
purity of each spore preparation, a Schaeffer and Fulton
endospore stain was routinely performed (Schaeffer and
Fulton, 1933). Results indicated that the purification process
effectively and reproducibly yielded spore titres of a high
purity, effectively free of vegetative cells (see Supplementary
Figure S1; Supplementary Table S2).
2.6 Soluble Fibre Blockade of Clostridioides
difficile-Intestinal Epithelial Cell Adhesion
Confluent Caco-2 cell monolayers in 24-well plates were pre-
treated for 30 min with or without soluble NSP from plantain
(0–20 mg/ml in antibiotic-free DMEM). Cell monolayers were
then infected with vegetativeC. difficile clinical isolates or purified
C. difficile spore preparations (1 × 107 CFU/ml), at a multiplicity
of infection (MOI) of 100, for 2 h. Each monolayer was then
washed three times with sterile PBS to remove non-adherent
bacteria or spores, and monolayers were lysed with sterile 1% v/v
Triton X-100. Epithelial adherent vegetative C. difficile and C.
difficile spores were both enumerated by performing serial
dilutions of cell lysates, plating of 20 µl aliquots of lysate to
BHIS agar (inclusive of 0.1% w/v sodium taurocholate for
spores) in triplicate. Plates were then incubated for 48 h at
37°C in anaerobic conditions, and CFU quantified.
In separate experiments, a variety of soluble dietary plant
fibres, including NSP isolated from dicots such as apple, runner
bean, blueberry, broccoli, celery, pear, bell pepper, strawberry and
tomato, were compared to NSP from the non-commelinoid
monocot leek, and the commelinoid monocots oat and
plantain. Each NSP was screened at 5 mg/ml for ability to
block C. difficile interactions with Caco-2 cell monolayers.
Additional experiments were also performed to determine
whether action of plantain NSP to block C. difficile adhesion
was via an interaction with the intestinal epithelial monolayer or
through direct interaction with bacteria. To test the former,
plantain NSP was added to Caco-2 cells 30 min prior to
infection as described above, but then removed by three
washes with sterile PBS (1 min each; at 37°C). Monolayers
were then provided with fresh antibiotic-free DMEM, infected
TABLE 1 | C. difficile strains used.
C. difficile
strain designation
Toxin A Toxin B Binary toxin Ribotype Geographic isolation
80042 + + + 027 Liverpool
98011 + + + 027 Liverpool
108536 + + + 027 Japan
98078 + + + 078 Liverpool
98231 + + + 078 Liverpool
108526 + + − 018 Japan
108906 + + − 012 Malawi
98359 + + − 106 Liverpool
1470 − + − 017 Belgium
108963 − + − 017 Liverpool
108519 − + − 017 Japan
108520 − + − 368 Japan
98220 − − − 010 Liverpool
1342 − − − 005 Oxford
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and levels of C. difficile adherent to cells assessed. To test for
direct interaction with bacteria, plantain NSP was incubated with
C. difficile for 30 min, followed by centrifugation, resuspension of
bacteria in antibiotic-free media and inoculation of epithelial
monolayers. To assess whether the inhibitory activity of soluble
NSP from plantain to block C. difficile-host intestinal epithelium
interactions lay within an acidic (pectin-rich) or neutral
polysaccharide component, Caco-2 monolayers were pre-
treated for 30 min with 5 mg/ml purified, desalted Q-
Sepharose anion-exchange NSP fractions, as previously
described (Parsons et al., 2014).
Alternative approaches were also used to assess the impact of
plantain NSP on C. difficile adhesion to Caco-2 cells, including
Giemsa staining coupled with light microscopy (as per (Roberts
et al., 2013)) and flow cytometry (based on the method of Drudy
and colleagues (Drudy et al., 2001). Briefly, C. difficile 080042 was
cultured anaerobically in 50 ml Fastidious Anaerobe Broth (Lab
M; Bury, United Kingdom) without shaking for 36 h, at 37°C.
Bacteria were washed and resuspended in sterile PBS, pH 7.3. For
fluorochrome labelling, 1 × 108 bacteria/ml were incubated with
1 μM of 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein,
acetoxymethyl ester (BCECF/AM) in the dark, at 37°C for 1 h.
Excess fluorochrome was removed by 5 sequential washes in
sterile PBS followed by centrifugation, each for 5 min. Bacteria
were re-suspended in PBS containing plantain NSP, or PBS alone
and incubated for 30 min in the dark, then added to 1 × 106 Caco-
2 cells in single cell suspension, at 37°C for 1 h. After incubation,
cells were washed three times in PBS (300 x g, for 20 min) to
remove any non-adherent bacteria. After the final wash, pellets
were resuspended in 1 ml PBS and subjected to flow cytometry
using a FACScan flow cytometer (Becton, Dickinson Ltd.;
Wokingham, United Kingdom). A total of 10,000 events were
acquired, with data analysed using Cell Quest software (Becton
Dickinson). Mean fluorescence intensity (MFI) using the
geometric mean of each sample was used to assess bacterial
adherence to Caco-2 cells.
2.7 Epithelial Cell Chloride Channel
Activation Assay
Cellular chloride secretion was assessed using a colorimetric assay
that measures cellular iodide efflux as a surrogate for monitoring
chloride ion channel activity, as per Tang and Wildey (2004).
Caco-2 cells were seeded in 96-well plates at 2.5 × 104 cells/well
and incubated for 24 h at 37°C. Cells were then loaded with 100 µl
pre-warmed iodine loading buffer and incubated for 4 h at 37°C.
Following three washes with sterile PBS, and incubated for 30 min
with plantain NSP (2.5–10 mg/ml) or chloride ion channel
agonists, forskolin (200 μM; Sigma) or RP107 (100 μM; Sigma)
as a positive controls (Noel et al., 2006). Following incubation,
cells were lysed with 1% (v/v) Triton X-100 in deionised water.
Intracellular iodine concentration was determined using the
modified Sandell-Kolthoff reaction, and absorbances measured
at OD410nm (Tang and Wildey, 2004). Chloride channel blockers,
cystic fibrosis transmembrane conductance regulator (CFTR)
inhibitor Inh-172 (12.5–200 μM; Sigma) (Linsdell, 2014), or 5-
nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, 50–800 μM;
Sigma) (Keeling et al., 1991), were evaluated for their ability to
block cellular chloride channel activation, and were present
during the 4 h iodine-loading step prior to incubation with
soluble NSP from plantain, RP107 or forskolin.
2.8 Treatment of Intestinal Epithelial Cells
and Organoids With Clostridioides difficile
Toxins
Purified C. difficile TcdA and TcdB, isolated from the highly toxic
strain reference strain VPI10463, were provided by Dr Clifford
Shone (Public Health England; Porton Down, United Kingdom)
(Maynard-Smith et al., 2014). Binary toxin (CDT) was generated
from combination (1:2) of purified component CDTa and
activated component CDTb (precursor CDTb digested with
trypsin), produced and purified from a ribotype 027 strain, by
Drs Panagiotis Papatheodorou and Carsten Schwan (Institute for
Experimental and Clinical Pharmacology and Toxicology,
Albert-Ludwigs University Freiburg, Germany) (Schwan et al.,
2009; Aktories et al., 2018).
Serial dilution of each toxin was made in sterile culture media
to achieve final test concentrations between 1–1,000 ng/ml. Caco-
2 cells were seeded at 2 × 105 cells/well in 6-well tissue culture
plates and incubated for 24 h. Following three washes with sterile
PBS, monolayers were pre-treatment for 30 min with or without
10 mg/ml soluble NSP from plantain. Cells were then treated with
toxins for up to 24 h.
Intestinal organoids, on day 4 of culture, were pre-treated with
10 mg/ml plantain NSP or saline vehicle, followed by treatment
with C. difficile toxins (1–100 ng/ml). Images were taken using an
Axiovert 25 microscope (Zeiss) and a 20X objective lens with a
Hitachi HV-C20A camera before treatment and 24 h post-toxin
treatment. Organoid circularity (as a measure of cytotoxicity) was
scored as previously described (Jones et al., 2019).
2.9 Immunoblot Assessment of Toxin-
Mediated Mono-Glucosylation of the
Intracellular GTP-Binding Protein, Rac1
C. difficile toxin mediated effects were assessed by immunoblot
using two monoclonal antibodies raised against Ras-related C3
botulinum toxin substrate (Rac1); clone 102 (BD Transduction
Lab; Oxford, United Kingdom) previously shown to lose affinity
for Rac1 following C. difficile toxin-mediated mono-glucosylation
(Gerhard et al., 2008) and clone 238a (Abcam; Cambridge,
United Kingdom) which recognises both non-glucosylated and
mono-glucosylated Rac1 isoforms (Gerhard et al., 2008). Cells
were lysed in ice cold 20 mM Tris-HCl buffer, pH 7.4. Whole-cell
protein lysates (25 µg) were separated using 4–20% acrylamide
gradient gels on SDS-PAGE at 150 V for 2 h, followed by electro-
transfer to nitrocellulose membrane (100 V, for 1 h).
Nitrocellulose membranes were blocked using 1% (v/v) bovine
serum albumin (BSA) in PBS containing 0.1% (v/v) Tween-20
overnight at 4°C, then incubated with primary antibody (1:1,000)
for 2 h at room temperature, followed by three 5 min washes with
PBS-0.1% (v/v) Tween 20. Blots were incubated with horse radish
peroxidase (HRP)-conjugated rabbit anti-mouse
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Immunoglobulin antibody (1:2,000) for 1 h at room temperature.
Membranes were again washed three times with PBS-0.1% (v/v)
Tween 20 and protein bands visualised with SuperSignal West
Dura Extended Duration Substrate (Thermo-Fisher Scientific;
Loughborough, United Kingdom) and quantified using Image
Lab Software v3.0.1 (Biorad; Hemel Hempstead,
United Kingdom).
2.10 Quantification of Inflammatory
Cytokine Release
Harvested media from human cell-lines was assayed for the
presence of pro-inflammatory IL-8 using a solid-phase
sandwich enzyme-linked immunosorbent assay (ELISA)
(Human Elipair Kit; Abcam, Cambridge, United Kingdom).
For murine intestinal organoid cultures, media was assayed for
the CXCL1/KC chemokine using a Duoset mouse CXCL1/KC
ELISA kit (R &D systems, Abingdon, United Kingdom). For both
assays, capture antibody in 0.5 M carbonate-bicarbonate buffer
(pH 9.6) was coated onto a 96-well high-binding γ-irradiated
ELISA plates (Costar) overnight at 4°C. Following three washes
with PBS-0.1% (v/v) Tween 20, plates were blocked with 1% (w/v)
bovine serum albumin for 2 h at room temperature. Triplicate
treatment samples (100 µl) of cell-free medium were then
incubated overnight at 4°C, plates washed three times with
12.0 µl wash buffer, and the respective biotinylated detection
antibody added for 2 h at room temperature. Subsequently,
ExtrAvidin peroxidase (Sigma; Poole, United Kingdom) was
added to each well, incubated for 20 min at room temperature.
Plates were again washed three times with PBS-Tween, developed
with SigmaFast o-phenylenediamine substrate (Sigma) for 10 min
and colour development stopped with 100 µl 4 M H2SO4. ELISAs
were measured on a Tecan Sunrise plate reader (Tecan; Reading,
United Kingdom) at OD492nm, with a reference filter set at
OD750nm. Treatment samples were quantified
against calibration curves of recombinant human IL-8
(0–2000 pg/ml) and mouse KC (0–1,000 pg/ml) standards in
culture medium.
2.11 Assessment of Cellular Apoptosis
Cells were seeded at 1 × 104 cells/ml in clear bottomed white wall
96-well tissue culture plates (Corning/Costar) and cultured
overnight at 37°C. Following treatment with purified toxins
and/or C. difficile clinical isolates, cell monolayers were
assayed using a commercial Caspase-Glo 3/7 assay (Promega;
Southampton, United Kingdom), as per manufacturer
instructions. Luminescence was detected using the Infinite
F200 plate reader (Tecan). Experiments were performed in
triplicate, with background luminescence determined from
wells containing culture medium alone.
2.12 Assessment of Cellular Cytotoxicity
Epithelial cell viability during NSP treatments and in response to
C. difficile infection or toxin treatment was monitored by
measurement of adenylate kinase (normally found within
intact cells) released to the culture medium from Caco-2 cells
using a ToxiLight bioassay (Lonza; Slough, United Kingdom).
Intestinal organoid cytotoxicity was measured as previously
described (Jones et al., 2019).
2.13 Statistical Analysis
Data are expressed as mean ± SD, unless otherwise stated. N
numbers indicate the total number of independent experiments
performed, where each experiment was performed with at least
n  3 replicates for any individual treatment group, unless
otherwise indicated. Independent sample groups were first
assessed for normality (Shapiro-Wilks test) and equality of
variances (Levene’s test). Two-sample comparisons were
performed using unpaired t-test or non-parametric Mann-
Whitney U test as appropriate. Multiple treatment groups
were analysed using either parametric one-way analysis of
variance (ANOVA) or non-parametric Kruskal-Wallis test
(Stats-Direct v3.0.171; Sale, United Kingdom). Differences
were considered significant when p < 0.05.
3 RESULTS
3.1 Soluble NSP From Plantain Inhibits
Intestinal Epithelial Adherence of
Clostridioides difficile Clinical Isolates,
Irrespective of Toxin Status and Ribotype
Soluble NSP from plantain was observed to dose-dependently
block adhesion of clinical C. difficile isolates to Caco-2 intestinal
epithelial cell monolayers. Peak inhibition of C. difficile adhesion
to Caco-2 cells was seen following pre-treatment with plantain
NSP at 10 mg/ml for ribotype 027, toxin positive isolate C. difficile
80042 (64.2 ± 4.4% inhibition) was seen compared to untreated
controls (N  3, n  3, p < 0.001, Kruskal-Wallis test), see
Figure 1A. Plantain NSP also dose dependently reduced C.
difficile adhesion of other C. difficile isolates, including the
ATCC reference strain C. difficile 1470 to Caco-2 cells (peak
inhibition seen at 10 mg/ml, 81.2 ± 2.4% in comparison to the
untreated control (N  3, n  3, p < 0.001); Figure 1A. Using the
optimum inhibitory dose of 10 mg/ml plantain NSP, similar
levels of blockade of C. difficile 80042 interaction to epithelial
cells was observed using two other colonic cell-lines SW620
(69.2 ± 3.0% inhibition) and SW480 (70.6 ± 1.4%) as was seen
using Caco-2 cells (75.6 ± 5.1%), compared to untreated controls
(N  3; p < 0.001, Mann-Whitney U test), Figure 1B. Alternative
approaches to measure bacterial adhesion, by flow cytometry
(Figures 1C,D) and Giemsa staining coupled with light
microscopy (Figure 1E), also revealed marked reduction in
adhesion of C. difficile to Caco-2 cells in the presence of
plantain NSP.
Plantain NSP (at 10 mg/ml) also significantly reduced
adhesion of a panel of C. difficile clinical isolates differing in
their geographical origin, toxin expression and PCR ribotype
(Table 1) to Caco-2 cells, with an overall median reduction for all
isolates tested of 73.8% (range 52.2–98.6%) in comparison to the
untreated inoculated monolayers (Figures 2A–D, for all; p <
0.001; Kruskal-Wallis test). These results demonstrate that the
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inhibitory effect of plantain NSP is independent of C. difficile
toxin expression and ribotype status.
3.2 Soluble NSP From Other Plant Sources
can Inhibit the Epithelial Adhesion of
Clostridioides difficile, but Not as Effectively
as NSP From Plantain
To screen for inhibitory activity, Caco-2 cell monolayers
underwent pre-treatment using soluble NSP from a range of
dietary plants prior to infection with C. difficile 80042
(Figure 3A). Pre-incubation of intestinal cells with 5 mg/ml
NSP from broccoli, leek and plantain resulted in the highest
levels of inhibition of C. difficile 80042 adhesion to Caco-2 cells
(>43% inhibition; p ≤ 0.01 (N  3, n  3–4 for broccoli NSP and
plantain NSP; N  1, n  3 for leek NSP). NSP from runner bean,
bell pepper or tomato was observed to be less effective (>22%
inhibition; p < 0.05) whilst others such as apple, blueberry, celery,
oat, pear and strawberry, had little or no inhibitory effect (N  3,
n  3–4); see Figure 3A. Further study of leek NSP and broccoli
NSP indicated a dose-dependent inhibitory effect on C. difficile-
epithelial cell adhesion, with peak inhibition seen at 20 mg/ml
(leek NSP, 57.5 ± 6.5%; and broccoli NSP, 56.9 ± 7.2% compared
to untreated controls (100%); both p < 0.001). Both these dietary
plant soluble fibres had a lower efficacy than that seen with
plantain NSP; used as a positive control at 10 mg/ml, where the
epithelial adhesion of C. difficile was reduced by 81.8 ± 4.6% (p <
0.001; N  3, n  3); see Figures 3B,C.
3.3 Soluble NSP From Plantain Inhibits the
Epithelial Adherence of Clostridioides
difficile via an Effect on the Intestinal
Epithelium
Plantain NSP appears to exert its inhibitory effect on C. difficile
adhesion via action on the epithelium. When plantain NSP
(10 mg/ml) was added to Caco-2 cell monolayers for 30 min,
then removed by three washes with sterile PBS, levels of adherent
C. difficile were observed to be significantly reduced (59.2 ± 5.0%)
compared to the untreated inoculated controls (p < 0.01; Kruskal-
FIGURE 1 | Soluble non-starch polysaccharides from plantain inhibits C. difficile adhesion to intestinal epithelial cells in a dose-dependent manner. (A) Adhesion of
C. difficile isolate 80042 to confluent Caco-2 [Caco2] monolayers are significantly inhibited in the presence of plantain (NSP). (B) Pre-treatment with 10 mg/ml plantain
NSP, blocked adhesion of C. difficile 80042 to three different intestinal cell-lines Caco-2, SW480 and SW620. Adhesion is expressed relative to CFU/mL found in the
absence of plantain soluble dietary fibre, set as 100% (N  3 experiments, n  3 replicates; **p < 0.01, ***p < 0.001; Kruskal-Wallis test or MannWhitney U test). (C)
Flow cytometric analysis of 1 × 106 Caco-2 cells in suspension, either uninfected (blue), co-incubated with 1 × 108 BCECF/AM-labelled C difficile 80042 for 1 h, either
without (green), or with 30 min pre-treatment with 10 mg/ml plantain NSP (pink). (D) Data are based on 10,000 events, and representative of N  4 separate
experiments. Significant effect of NSP, as assessed by shift in mean fluorescence intensity, compared to infected controls (**p < 0.01, Kruskal-Wallis test). (E) Giemsa-
stained C. difficile 80042 inoculated Caco-2 cells in the absence and presence of 10 mg/ml plantain NSP. Black arrows indicate adherent bacteria.
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Wallis test), albeit lower than that seen in experiments where
plantain NSP was added to cells for 30 min without removal
before infection (92.9 ± 2.0%, compared to the untreated control;
p < 0.001; Kruskal-Wallis test). In contrast, pre-incubation of
plantain NSP directly with bacteria for 30 min, followed by
removal of soluble dietary fibre from bacteria by
centrifugation, resulted in no significant inhibition of C.
difficile adhesion compared with untreated controls (see
Supplementary Figure S2).
In addition, treatment of Caco-2 cells with 2.5–20 mg/ml
plantain NSP also resulted in a dose-dependent increase in
cellular chloride ion channel activity, with peak activity at
20 mg/ml plantain NSP (5.4 ± 0.4-fold increase in comparison
to the untreated control; p < 0.001 Kruskal-Wallis test, N  3, n ≥
3). This level of activation was similar to that seen with chloride
ion channel agonists forskolin (200 μM) and RP107 (100 μM),
which increased chloride ion channel activity by 5.4 ± 0.5 and
8.2 ± 1.0-fold respectively, in comparison to the untreated vehicle
controls (p < 0.001). Other dietary plant NSP’s (at 5 mg/ml),
previously shown to have little or no inhibitory action on C.
difficile adhesion to Caco-2 cells, exhibited less efficacy with oat
and runner bean NSP increasing chloride ion channel activity at a
much lower levels (2.2 ± 0.6 and 2.0 ± 0.3 fold, respectively; both
p < 0.001), with tomato, pear, bell pepper and apple NSP actually
reducing chloride ion channel activity in comparison to the
untreated controls (see Supplementary Figure S3). Chloride
ion channel activity in Caco-2 cells induced by 10 mg/ml
plantain NSP, was significantly inhibited by inhibitors NPPB
and Inh-172 in dose-dependent manner; with peak levels of
inhibition seen using 800 µM NPPB and 200 µM Inh-172,
reducing chloride efflux by 94.7 ± 10.0% and 86.9 ± 8.5%
respectively, in comparison to the vehicle-treated controls
(both p < 0.001). However, bacterial interaction assays
indicated that in the presence of NPPB or Inh-172, pre-
treatment of Caco-2 cells with 10 mg/ml plantain NSP still
possessed significant ability to reduce C. difficile 80042
FIGURE 2 | Soluble NSP from plantain inhibits the epithelial adhesion of a panel of C. difficile clinical isolates differing in toxin expression and ribotype. Caco-2
[Caco2] cells underwent pre-treatment with 10 mg/ml plantain NSP for 30 min prior to inoculation with C. difficile at a multiplicity of infection (MOI) of 100. Plantain NSP
significantly inhibited adhesion to Caco-2 cell monolayers, of C. difficile clinical isolates positive for (A) all toxins (A, B and binary), (B) positive for toxin A and toxin B, (C)
Toxin B only, and (D) toxin null strains. Clinical laboratory C. difficile isolate 80042 (ribotype 027) was used as a positive reference for plantain NSP inhibition of
bacteria-epithelial cell adhesion, with adhesion to Caco-2 cells expressed relative to CFU/mL found in each untreated control (set as 100%). Significant differences from
untreated control, ***p < 0.001, N  3 experiments, n  3 replicates; Kruskal-Wallis test).
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adhesion. C. difficile adhesion to Caco-2 cells was significantly
decreased when treated with chloride ion channel agonist.
RP107, with an observed reduction in adhesion of 23.7 ± 9.0%
(at 100 μM), from vehicle treated controls (set at 100%) (p < 0.01;
Kruskal-Wallis test), with this action reversed in the presence of
chloride ion channel antagonists NPPB or Inh-172, increasing
bacterial adhesion by 7.9 ± 8.1% and 4.5 ± 4.1% respectively above
the level seen in controls (100%); see Supplementary Figure S3).
3.4 The Inhibitory Effect of Plantain NSP on
Clostridioides difficile Intestinal Epithelial
Cell Adherence is Mediated Primarily by the
Acidic (Pectin-Rich) Polysaccharide
Fraction
At 5 mg/ml, the acidic (pectin-rich) polysaccharide fraction of
plantain NSP, significantly blocked adhesion of C. difficile isolate
080042 to intestinal Caco-2 cell-line by 52.3 ± 7.2% (p < 0.01),
and was at least as effective as the unfractionated plantain soluble
fibre, which reduced adhesion by 62.3 ± 17.1% (p < 0.01).
Conversely, pre-treatment of Caco-2 cells with 5 mg/ml
neutral polysaccharide fraction (unbound to Q-Sepharose) of
plantain NSP showed significantly reduced ability to inhibit C.
difficile epithelial adhesion (Figure 4).
3.5 Soluble NSP From Plantain Inhibits the
Epithelial Adherence of Clostridioides
difficile Spores
Soluble NSP from plantain, at 10 mg/ml, significantly reduced the
adhesion of all five C. difficile isolate spore preparations to Caco-2
cells, with inhibition ranging from 27.9 ± 5.4% to 33.8 ± 6.9% (all
p ≤ 0.05, Kruskal-Wallis test); see Table 2. Blockade of spores was
less than that observed with the corresponding vegetative C.
difficile bacterium, from which the spores were purified, at the
same MOI 100, where pre-incubation with 10 mg/ml plantain
NSP resulted in inhibition ranging from 78.9 ± 3.1% to 97.9 ±
1.5% (for all, p < 0.001). It is worth noting that C. difficile
spores (from all isolates) showed markedly greater adhesion to
Caco-2 cells (85 ± 7.3% versus 4.0 ± 0.6% adhesion of the original
FIGURE 3 | Evaluation of a range of dietary plant soluble non-starch polysaccharides (NSP) for their ability to prevent the adhesion ofC. difficile to intestinal epithelial
cells in vitro. (A) Adhesion ofC. difficile isolate 080042 to confluent Caco-2 [Caco2] cells monolayers is significantly inhibited in the presence of 5 mg/ml NSP from runner
bean, broccoli, leek, bell pepper, plantain and tomato. Further analysis showedC. difficile epithelial adhesion to be reduced in a dose dependent manner by, (B) leek NSP
and (C) broccoli NSP, compared to blockade seen with 10 mg/ml plantain NSP. Adhesion was measured as relative to CFU/mL quantified in the absence of NSP
(set as 100%). All N  3 experiments, n  3–4; excepting for leek NSP (N  1, n  3); *p < 0.05, **p < 0.01 and ***p < 0.001; Kruskal-Wallis test).
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inoculum of spores and vegetative cells (1 × 107 CFU/ml),
respectively; N  5 isolates).
3.5 Soluble NSP From Plantain Reduces
Clostridioides difficile Toxin A/B-Induced
Inflammation and Cytotoxicity, But Does
Not Block Toxin-Mediated Rac1 Mono-
Glucosylation Within Intestinal Epithelial
Cells
3.5.1 Plantain NSP Blockade of Clostridioides difficile
Toxin A/B-Induced Inflammation
C. difficile toxins A (TcdA) and B (TcdB) both elicited dose-
dependent increases in release of pro-inflammatory cytokine IL-8
from Caco-2 cells, which were seen to be significantly blocked by
30 min pre-treatment with 10 mg/ml plantain NSP. The peak
induced response seen with 100 ng/ml TcdA (445.1 ± 30.9 pg/ml
IL-8 released) was reduced by 10 mg/ml plantain NSP to 270.9 ±
21.1 pg/ml (p < 0.001;N  2, n  3; Kruskal-Wallis). Treatment of
Caco-2 cells with C. difficile 98011 (TcdA+, TcdB+ and CDT+) at
MOI 100 for 4 h, IL-8 release increased from basal levels of
206.7 ± 7.8 pg/ml to 915.5 ± 20.6 pg/ml, and in the presence of
10 mg/ml plantain NSP, C. difficile mediated IL-8 release was
decreased to 683.6 ± 63.7 pg/ml (p < 0.05); see Figure 5A.
Similarly, 100 ng/ml TcdB-induced IL-8 release was also seen
to be blocked by plantain NSP from 228.2 ± 18.5 pg/ml to 96.0 ±
3.3 pg/ml (both p < 0.001; N  2, n  3; Kruskal-Wallis test). Of
note, the IL-8 response seen 4 h post-infection with the C. difficile
108519 (expressing TcdB only) was lower (at only 366.5 ±
31.0 pg/ml) than that seen with C. difficile 98011 expressing all
three toxins (p < 0.001). Pre-treatment with 10 mg/ml plantain
NSP also decreased C. difficile 108519 (TcdB+ only) mediated IL-
8 release from Caco-2 cells (2.8-fold decrease; p < 0.001);
Figure 5B. It was also noted that Caco-2 cell monolayers that
underwent pre-treatment with 10 mg/ml plantain NSP but
received no subsequent treatment with C. difficile toxins nor
bacteria, showed marked decreases in basal secreted levels of IL-8;
Figures 5A,B.
3.5.2 Plantain NSP Blockade of Clostridioides difficile
and Toxin-Induced Cytotoxicity
C. difficile bacterium and toxin-mediated apoptosis (caspase-3/7
activation) was also monitored in the absence and presence of
plantainNSP.C. difficile toxins elicited cellular caspase-3 activation
in a dose-dependentmanner, with peak response seen at 100 ng/ml
for both TcdA and TcdB (see Figures 5C,D). As per toxin-induced
IL-8 release, caspase-3/7 activation was observed to be higher in
Caco-2 cells that had been treated with TcdA. Pre-treatment of
cells with 10mg/ml plantain NSP resulted in a significant decrease
in toxin-mediated caspase-3/7 activation (e.g. 100 ng/ml TcdA,
63.8 ± 1.6% reduction and 100 ng/ml TcdB, 58.2± 10.4% reduction
in caspase3/7 activation (both p < 0.05). Following 4 h infection of
Caco-2 cells with C. difficile 98011 (expressing all toxins) there was
a 13.1 ± 3.3-fold increase in caspase-3/7 activation in comparison
to the untreated controls. In the presence of 10 mg/ml plantain
NSP, there was a significant reduction inC. difficile 98011mediated
caspase-3/7 activation (84.1 ± 7.0% reduction compared that seen
in absence of plantain NSP, p < 0.001;N  2, n  3; Kruskal-Wallis
test); see Figure 5C. Cellular caspase-3/7 activity was also increased
(10.1 ± 1.6 fold) after infection with C. difficile 108519 (TcdB
expressing only) albeit at a lower level than that seen with C.
difficile 98011 (Figure 5D). Again, pre-incubation with 10mg/ml
plantain NSP resulted in a marked reduction (87.6 ± 1.4%) in
bacteria-induced caspase 3/7 activation (p < 0.001). As was seen
with IL-8 response, there was a small, but notable, decrease in
caspase 3/7 activation in cells pre-treated with plantain NSP alone.
As seen with other toxin-mediated effects, C. difficile toxins
TcdA and TcdB evoked a dose-dependent increase in adenylate
kinase release from Caco-2 cells, with the peak responses seen at
100 ng/ml for both toxins (Figures 5E,F). Again, adenylate kinase
release was significantly higher in cells treated with TcdA (8.2 ±
0.9-fold increase) compared to TcdB (1.8 ± 0.2-fold increase); p <
0.001; N  2, n  3. Pre-incubation with 10 mg/ml plantain NSP
FIGURE 4 | The inhibitory activity of soluble NSP from plantain to block
C. difficile-host intestinal epithelium interaction lies within an acidic (pectin-rich)
polysaccharide component. At 5 mg/ml, the Q-Sepharose purified acidic
polysaccharide fraction of plantain NSP significantly blocked adhesion of
C. difficile to confluent Caco-2 [Caco2] cell monolayers, whereas the neutral
fraction had no significant effect compared to the untreated control (N  3
experiments, n  3 replicates, **p < 0.01, Kruskal-Wallis test).
TABLE 2 | Soluble NSP from plantain inhibits epithelial adhesion of C. difficile
spores and vegetative cells.






98011 30.3 ± 5.2* 93.4 ± 1.9***
108536 33.8 ± 6.9* 92.6 ± 4.3***
108526 27.9 ± 5.4** 86.7 ± 2.0***
98220 29.9 ± 8.9** 78.9 ± 3.1***
1342 32.8 ± 14.9** 97.9 ± 1.5***
aReduction in adhesion of purifiedC. difficile isolate spores and vegetative cells to Caco-2
cells expressed as a percentage of untreated controls, set as 100%. Caco-2 cells were
pre-treated with 10 mg/ml plantain non-starch polysaccharides (NSP) for 30 min before
inoculation (1 × 107 CFU/ml; multiplicity of infection, MOI 100). Significant differences
from untreated controls, *p < 0.05, **p < 0.01 and ***p < 0.001 (data expressed as
mean ± SEM for N  2–4 experiments, n  3 replicates; Kruskal-Wallis test).
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significantly decreased adenylate kinase release in 1, 10, and
100 ng/ml TcdA- and TcdB-treated cells (all doses, p ≤ 0.01).
As an example, pre-treatment with plantain NSP in cells treated
with 100 ng/ml TcdA and TcdB lead to significant decrease in
adenylate kinase release by 63.3 ± 4.1% and 35.7 ± 9.2%,
respectively (both p < 0.001; see Figures 5E,F). Following 4 h
infection of Caco-2 cells with C. difficile 98011, an 8.9 ± 0.3-fold
increase was observed in adenylate kinase release in comparison
to untreated controls, which was significantly decreased in cells
pre-incubated with 10 mg/ml plantain NSP (47.3 ± 1.03%
reduction; p < 0.001; Figure 5E). Whilst adenylate kinase
release increased by 2.1 ± 0.3-fold in cells infected with C.
difficile 108519 (expressing TcdB only), the response was
lower than that seen with C. difficile 98011 (expressing all
FIGURE 5 | Soluble NSP from plantain reduces C. difficile bacterium and toxin A and toxin B mediated inflammation, cellular apoptosis and cytotoxicity in intestinal
epithelial cells. Caco-2 cell monolayers were treated with C. difficile toxins A (TcdA) or toxin B (TcdB), at 1–100 ng/ml for 24 h, in the absence (black bars) or presence of
10 mg/ml plantain NSP (white bars). In parallel, Caco-2 cells were infected with the TcdA+/TcdB+/CDT + C. difficile isolate 98011 or the TcdB + C. difficile isolate
108519, at a multiplicity of infection (MOI) of 100 for 4 h, again in the absence or presence of plantain NSP. Media harvested from cells was analysed for release of
IL-8 (by ELISA) and cytotoxicity marker adenylate kinase (by Toxilight bioassay). Apoptotic cell death was measured using the Caspase Glo 3/7 assay. In the presence of
plantain NSP, TcdA- and TcdB-mediated (A,B) IL-8 release, (C,D) caspase 3/7 activation, and (E,F) cytotoxicity (intracellular adenylate kinase release) were all
significantly reduced (N  2, n  3; *p < 0.05, **p < 0.01, ***p < 0.001; Kruskal-Wallis test).
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toxins), with pre-incubation of Caco-2 cells with 10 mg/ml
plantain NSP resulting in significant reduction of cellular
adenylate kinase release (56.2 ± 1.9%) in comparison to that
seen in the absence of plantain NSP (p < 0.001; Figure 5F). In
some experiments, basal levels adenylate kinase release appeared
to be lower in Caco-2 cells receiving with plantain NSP alone.
Treatment of stem cell derived 3-D intestinal organoids from
C57BL/6J mice with purified C. difficile toxins, both TcdA and
TcdB, dose-dependent increased organoid rounding
(cytotoxicity) over 24 h. Morphological changes induced by
100 ng/ml TcdA (circularity score, 0.64 ± 0.05 [mean ± SD])
and TcdB (0.71 ± 0.09) were similar to that seen following
treatment with 100 ng/ml TNFα (0.71 ± 0.08); compared to
untreated controls (0.38 ± 0.03); N  4; p < 0.01 one-way
ANOVA, see Supplementary Figure S4. Pre-treatment of
organoids with 10 mg/ml plantain NSP 30 min prior to
addition of toxin, reduced the level of cytotoxicity induced by
all doses of TcdA and TcdB. At 100 ng/ml, TcdA mediated
circularity (0.69 ± 0.12) was reduced to 0.50 ± 0.13, and TcdB
induced circularity reduced from 0.72 ± 0.10 to 0.54 ± 0.12]; N 
4; both p < 0.01 (see Figure 6). Levels of chemokine CXCL1/KC
dose-dependently released to the medium from toxin-treated
organoids, were also observed to be reduced by pre-treatment
of cultures with 10 mg/ml plantain NSP. CXCL1/KC released
from organoids treated with 100 ng/ml TcdA or TcdB (409.4 ±
31.7 pg/ml or 532.9 ± 28.1 pg/ml released to media in 24 h) were
reduced with plantain NSP by 67.7 ± 4.3 pg/ml and 65.8 ± 4.8 pg/
ml respectively; both p < 0.01 one-way ANOVA.
3.5.3 Plantain NSP Does Not Block of Clostridioides
difficile Toxin A- and Toxin B-Induced Intracellular
Glucosylation of Rac1
Treatment of Caco-2 cells with 10 ng/ml TcdA elevated
cellular levels of mono-glucosylated Rac1 (as indicated by a
loss of binding of antibody clone 102 to Rac1) 10 h post-toxin
treatment, with peak mono-glucosylation of Rac1 observed at
24 h compared to vehicle-treated control cells; N  3, n  3; p <
0.01 (see Supplementary Figure S5). Treatment of cells with
10 ng/ml TcdB also revealed elevated cellular levels of mono-
glucosylated Rac1, but this was only significant 48 h post-toxin
treatment; N  3, n  3; p < 0.01 (see Supplementary Figure
S5). Notably, neither TcdA nor TcdB mediated mono-
glucosylation of intracellular Rac1 was seen to be blocked in
Caco-2 cells pre-treated with 10 mg/ml plantain NSP (see
Figure 7).
3.6 Pre-treatment With Plantain NSP
Reduces the Pathogenic Effects of
Clostridioides difficile Binary Toxin in
Intestinal Epithelial Cells
Treatment of SW480 colonocytes with C. difficile binary toxin
(CDT) dose-dependently increased cytotoxicity, as measured by
enhanced caspase 3/7 activity, with peak response seen at 10 ng/
ml CDT (283,890 ± 125,878 RFU) compared to untreated
controls, 109,333 ± 35,941 (p < 0.05 Kruskal-Wallis test; N 
2, n  3). Pre-treatment with plantain NSP inhibited the dose-
dependent cytotoxicity induced by CDT, with peak reduction in
toxin-treated SW480 colonocytes occurring at 100 ng/ml CDT
(259,914 ± 67,103 RFU) which was reduced by >70% to 73,060 ±
53,767 (N  2, n  3; p < 0.001); see Figure 8A. Similarly,
treatment with CDT also effected a dose-dependent increase in
release of pro-inflammatory IL-8 from SW480 cells, with peak
response seen at 100 ng/ml CDT (1041.92 ± 84.11 pg/ml/24 h)
compared to untreated controls, 27.33 ± 10.81 pg/ml/24 h (p <
0.001). Again, it was seen that pre-treatment with plantain NSP
inhibited the dose-dependent actions of CDT, with peak IL-8
release in toxin-treated SW480 colonocytes occurring at 100 ng/
FIGURE 6 | Soluble NSP from plantain inhibits C. difficile toxin-induced cytotoxicity in intestinal crypt stem cell-derived organoids. Intestinal organoid cultures were
pre-treated for 30 min with 10 mg/ml plantain NSP before treatment with 10 and 100 ng/ml ofC. difficile toxins, (A) TcdA or (B) TcdB. Plantain NSP significantly reduced
TcdA- and TcdB-induced cytotoxicity (as assessed by rounding/circularity score) compared to vehicle (sterile PBS, pH 7.3) pre-treated controls. Organoid rounding was
quantified as previously described (Parsons et al., 2015), with circularity values possible between 0 and 1, and where a score of 1 indicates a perfect circle. Data
expressed as mean ± SD (N  4). Significant differences of toxin-induced response to untreated controls, ##p < 0.01, ###p < 0.001, and plantain NSP versus vehicle pre-
treated controls; **p < 0.01; One-way ANOVA, with Dunnett’s post-hoc test.
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ml CDT reduced by approximately 50%, to 540.67 ± 41.21 pg/ml
(p < 0.001); see Figure 8B.
CDT was also observed to induce release of inflammatory IL-8
from Intestine-407 cells, at test concentrations of 10 and 100 ng/
ml over 24 h (both p < 0.001 one-way ANOVA;N  2, n  3). Pre-
incubation of Intestine-407 cells with 10 mg/ml plantain NSP,
reduced the amount of IL-8 released to the medium by both 10
and 100 ng/ml CDT (both p < 0.01; N  2, n  3 Kruskal-Wallis
test). Plantain NSP was also effective in reducing Intestine-407
cytotoxicity induced by CDT (p < 0.05). No such inhibitory
activity was seen with pre-treatment using 10 mg/ml oat NSP; see
Supplementary Figure S6).
4 DISCUSSION
Dietary fibre is widely recognised as being beneficial for intestinal
health. A high dietary fibre intake increases faecal bulking and
FIGURE 7 | C. difficile toxins A and B mediate increased Rac1 glucosylation within intestinal epithelial cells, which is unaffected by pre-treatment with soluble NSP
from plantain. Immunoblot analysis shows an increase in Rac1 glucosylation following treatment with 10 ng/ml (A) toxin A (TcdA) for 24 h and (B) toxin B (TcdB) for 48 h,
which is unaffected by pre-treatment of Caco-2 cells with 10 mg/ml soluble plantain NSP (P). Protein bands were analysed by chemiluminescence image densitometry.
Mono-glucosylated Rac1 levels (assessedwith antibody 102) were normalised to total Rac1 (assessed with antibody 238a), with representative blots shown forN 
3 experiments, n  3 replicates. Significant differences from non-toxin treated controls, *p < 0.05, **p < 0.01 and ***p < 0.001; Kruskal-Wallis test.
FIGURE 8 | Soluble NSP from plantain counters the pathogenic actions of C. difficile binary toxin (CDT) on human colonocytes. Treatment of the SW480 colonic
cell-line with C. difficile binary toxin (CDT, 1–100 ng/ml for 24 h) resulted in dose-dependent induction of (A) apoptosis and (B) inflammation, which was significantly
attenuatedwith plantain NSP pre-treatment (at 10 mg/ml for 30 min). Apoptosis was assessed by caspase 3/7 Glo assay (RFU, relative fluorescence emission units), and
pro-inflammatory cytokine IL-8 secreted to culture medium was assessed by ELISA. Data expressed as mean ± SD. Significant differences of toxin-treated cells
from untreated controls; #p < 0.05, ##p < 0.01, ###p < 0.001 and between plantain NSP and vehicle pre-treated cells, *p < 0.05, **p < 0.01, ***p < 0.001; Kruskal-Wallis
test; N  2 experiments, n  3 replicates.
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viscosity, resulting in shortened transit time through colon
(Lattimer and Haub, 2010). Furthermore, its fermentation by
resident gut microbiota produces short-chain fatty acids (SCFAs),
such as butyrate, that act as an energy source for the intestinal
epithelium (Kumar et al., 2020) and possess anti-carcinogenic
properties (Chapkin et al., 2020). Fibre has also attracted
considerable attention due to its role in the prebiotic effect,
where it may selectively promote the growth of resident
beneficial bacteria, through generation of butyrate to support
intestinal health (Simpson and Campbell, 2015; Kumar et al.,
2020). Here, we further suggest an alternative role of soluble
dietary fibre as a “contrabiotic,” i.e. countering the action of
microbes (Flanagan et al., 2011; Kumar et al., 2020).
In these studies, we provide additional evidence supporting
the inhibitory effect of plantain NSP against diarrhoeal pathogen
adhesion, specifically with respect to C. difficile. In further
validation experiments, plantain NSP consistently inhibited the
epithelial adherence of a range of clinically relevant C. difficile
isolates. As these isolates varied according to their ribotype and
toxin status, our results have suggested that the inhibitory activity
of plantain NSP is likely independent of these two factors. We
demonstrate that whilst a range of plant soluble fibres do
significantly inhibit the epithelial adhesion of C. difficile,
plantain NSP exhibits a particularly strong inhibitory effect.
This is consistent with its superior blockade of adherence and
invasion by a range of other pathogens including various E. coli
and Salmonella species. Other evidence supporting a protective
effect of plantain against diarrhoeal disease includes randomised
controlled trials in which the juice from boiled green bananas has
been shown to be effective in a variety of diarrhoeal diseases
(Rabbani et al., 2001; Rabbani et al., 2004; Alvarez-Acosta et al.,
2009).
Here, we also provide further insight into the mechanism of
the inhibitory action of plantain soluble non-starch
polysaccharides. We present data indicating that plantain
soluble dietary fibre likely exerts its inhibitory effect against C.
difficile via an interaction with the intestinal epithelium, rather
than through interaction with bacterial adhesins. This is similar
to the mechanism we have previously reported for plantain NSP
blockade of Salmonella spp. adhesion with, and invasion into,
intestinal epithelial cells (Parsons et al., 2014). Ussing chamber
experiments had also shown that pre-treatment of human
terminal ileum with plantain NSP generated an increase in
transmucosal short circuit current (Isc), indicative of
electrogenic chloride ion efflux and associated water transport
(Parsons et al., 2014). Epithelial secretion of fluid is already
recognised as a form of innate immunity, thought to serve as
a non-specific method of clearing bacteria and their toxins from
the intestinal mucosa (Keely et al., 2011). Therefore, it is plausible
that plantain NSP could act in this manner to reduce C. difficile
epithelial adhesion. We found that plantain NSP increased
chloride ion efflux from Caco-2 cell monolayers in a dose-
dependent manner. Due to limited available quantities of other
dietary plant NSP sources, we could only test for their ability to
induce epithelial cell chloride ion channel activity at a dose of
5 mg/ml. Compared to plantain NSP at this level, which showed
approximately 70% inhibition of bacterial adhesion, and 4-fold
enhancement of chloride ion channel activity, other dietary plant
NSP sources, shown not to exhibit an inhibitory effect on
bacterial adhesion, had weaker, or no such, activity. However,
whilst we showed that elevated epithelial cell chloride ion channel
activity induced by plantain NSP could be significantly
suppressed in the presence of chloride ion channel
antagonists, under these same conditions, plantain NSP still
possessed significant ability to reduce C. difficile-epithelial cell
adhesion. Further insight into the action of plantain NSP on key
chloride ion transporters in intestine and colon, coupled with
in vitro bacterial adhesion assays will be necessary.
In our in vitro studies presented here, only soluble NSP from
one dicot—broccoli—and from the non-commelinoid monocot
leek showed inhibitory effects against C. difficile-epithelial
interactions comparable to plantain NSP (a commelinoid
monocot). NSP from the other eight dicots tested and from
the commelinoid monocot oat were mainly ineffective, or
showed low efficacy at best. That the desired inhibitory effects
can be obtained by utilising NSP from dicots, commelinoid and
non-commelinoid monocots suggests that efficacy is not related
to cell wall type. Dicots and non-commelinoid monocots have
type I cell walls, formed from a cross-linked but relatively open
network of cellulose and xyloglucans, with smaller amounts of
linked arabinoxylans, glucomannans and galactoglucomannans
(Vogel, 2008; Pattathil et al., 2015). A pectin-based matrix
envelops the cellulose-xyloglucan network, contributing up to
one third of the cell wall dry weight. Pectins can be sub-divided to
three distinct groups; homogalacturonan and
rhamnogalacturonans, RGI and RGII (Fry, 2004; Atmodjo
et al., 2013). These polymers are covalently linked, with the
rhamnogalacturonans typically containing a high proportion of
neutral sugars, such as arabinose, rhamnose and galactose (Fry,
2011). Commelinoid monocots have type II cell walls; these are
composed of a tightly packed network of
glucuronoarabinoxylans, mixed-link glucans such as β-glucans,
and a relatively larger amount of cellulose, compared to type I
walls (Cui and Wang, 2009). Type II cell walls are relatively
pectin-poor, especially in the Poaceae, but pectins are known to
occur in higher amounts in bananas and plantain. Thus, it is
evident that the inhibitory NSP preparations discovered in our
work, deriving from different cell wall types, could have very
different polysaccharide compositions. From the data discussed,
it is difficult to discover whether the inhibition of C. difficile-
epithelial interactions by plantain, broccoli and leek NSP has a
common cause, or whether the observed effects are due to
completely different polysaccharide interactions.
However, in further work presented here, the inhibitory
activity of plantain NSP against C. difficile-epithelial
interaction is shown to be due to the acidic (or pectin-rich)
fraction within this particular soluble dietary fibre, whilst little or
no inhibition occurred with the neutral fraction (the larger
proportion of total NSP). These results also support observed
blockade of Salmonella Typhimurium to intestinal epithelial cells
with the acidic fraction of plantain NSP (Parsons et al., 2014). The
pectin component of plantain NSP is known to contain
significant quantities of homogalacturonan, and much smaller
amounts of RG-I; our previous studies have shown that the
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inhibitory activity associated with the acidic fraction of plantain
NSP is linked to the homogalacturonan component (no RG-I/
RG-II was detected in the active fraction) (Parsons et al., 2014).
This is interesting, because water-soluble pectin from broccoli is
reported to be composed of unbranched, highly-esterified pectin
(homogalacturonan) alongside less abundant pectic polymers
with side-chains that are less esterified (Christiaens et al.,
2011), and leek pectin is reported to consist largely of
relatively high methyl-esterified homogalacturonan with
smaller quantities of RG-I decorated with galactose-rich side
chains (Ognyanov et al., 2020). In contrast, pectins from the
dicots which did not show significant inhibitory activity against
C. difficile-epithelial interactions - strawberry, blueberry, tomato,
celery, runner bean, pear and apple—have been reported to
contain both RG-I and II subtypes in significant proportions,
with less unbranched homogalacturonan (Lefever et al., 2004;Wu
et al., 2020; Hotchkiss et al., 2021); and oat NSP contains hardly
any pectins at all. It is possible that the homogalacturonan
content of plantain, broccoli and leek NSP may be a
commonality which underlies the inhibitory activity shown,
although in the current absence of data on broccoli and leek
NSP this is clearly a speculative hypothesis. In future work, it will
be interesting to examine whether the proportion of
homogalacturonan in pectic polysaccharides has a direct
bearing on NSP inhibitory potential. There is currently a
strong focus on RG-I as a source of dietary polysaccharides
beneficial to health (Wu et al., 2020), but pectic
polysaccharides are among the most complex in the plant cell
wall and our in vitro data shows that other possibilities should not
be overlooked.
Other dietary factors rich in complex oligosaccharides, such as
human milk, are also well established as being able to prevent
bacteria-host epithelium interactions (Asadpoor et al., 2020),
inhibiting adhesion of bacteria such as Campylobacter jejuni
and Salmonella enterica (Asadpoor et al., 2020), diffusely
adherent E. coli (DAEC) (Nascimento de Araújo and
Giugliano, 2000) and enteroaggregative E. coli (EAEC)
(Nascimento de Araújo and Giugliano, 2000). More
specifically, pectic oligosaccharides have also been
demonstrated to inhibit C. jejuni intestinal epithelial
adherence in vitro (Ganan et al., 2010). In addition, pectin
from ginseng has been shown to possess anti-adhesive activity
against other gut pathogens such asHelicobacter pylori, and some
ability to inhibit haemagglutination by bacteria, including that
caused by Staphylococcus aureus and Propionibacterium acnes
(Lee et al., 2006a). An acidic polysaccharide extract from green
tea (Camellia sinensis) has also been shown to possess inhibitory
activity, blocking adhesion ofH. pylori, as well as S. aureus and P.
acnes (Lee et al., 2006b).
It is a reasonable assumption that ingested soluble fibre from
plantain should pass through the human small intestine intact.
Given a typical passage of approximately 1 L of fluid per day into
the caecum, a daily intake of 10 g of soluble fibre should therefore
result in a concentration of 10 mg/ml, as tested here, in the
caecum but it is then likely to be fermented quite rapidly (Roberts
et al., 2010). In keeping with this it is notable that the large EPIC
cohort study showed a protective effect for dietary fibre against
proximal but not distal colon cancer (Murphy et al., 2012) and the
Nurses’Health cohort study has shown a protective effect for fruit
fibre against Crohn’s disease, which typically affects the ileum and
caecum, but not against ulcerative colitis, which typically affects
the distal colon and rectum (Ananthakrishnan et al., 2013). It is
plausible though that the rate of fermentation of plantain fibre
might be considerably diminished during diarrhoeal disease thus
allowing a protective effect in the distal colon.
Although controversy exists as to whether C. difficile epidemic
strains do actually have significantly high sporulation rates
(Akerlund et al., 2008; Burns et al., 2010; Merrigan et al., 2010),
studies suggest that C. difficile spores can in fact persist within the
intestinal tract due to their ability to interact with, and adhere to, the
intestinal epithelium (Paredes-Sabja and Sarker, 2012). In our
studies, we observed that 85% of C. difficile spores adhered to
human intestinal Caco-2 cells, in comparison to only 4% of C.
difficile vegetative cells. Our results are in agreement with those of
previous studies, which have also shown that C. difficile spores are
much more adhesive to monolayers of Caco-2 cells (Dingle et al.,
2010; Paredes-Sabja and Sarker, 2012) and provide further evidence
to suggest that spore adherence might be exploited by C. difficile as a
means of persistence in the host. It is worth noting, that the
purification procedure to obtain C. difficile spores includes
treatment with proteinase K, removing proteins from the external
exosporium layer (Escobar-Cortés et al., 2013). This not only
enhances adherence of C. difficile spores, both to inert surfaces
and to intestinal epithelial cells in culture, including Caco-2, but also
increases colony forming efficiency (Escobar-Cortés et al., 2013). It is
speculated that the exosporium acts physically to slow escape of a
new vegetative cell from a germinated spore so as to allow for correct
timing of outgrowth and colonisation of the intestinal epithelium
(Escobar-Cortés et al., 2013). The low level of interaction of
vegetative cells with intestinal cell monolayers in culture, in
comparison to that seen for spores, might also reflect that C.
difficile, although able to germinate in an aerobic environment,
cannot grow and divide in the presence of the levels of oxygen seen
for cell-linemonolayer culture (Sorg and Sonenshein, 2010), albeit in
our infection assays, exposure was relatively short-term, over 2 h.
Recent bioengineered 3D human intestinal tissue models that
recapitulate the lower O2 conditions produced in the lumen of
these tissues (Shaban et al., 2018) may better support longer term
studies ofC. difficile vegetative cell and spore-epithelium interactions
under anaerobic conditions. Perhaps more importantly, our results
demonstrate that soluble NSP fromplantain significantly inhibits the
epithelial adhesion of C. difficile spores. Persistence of C. difficile
spores within the colon of CDI patients not only complicates
treatment options, but also increases recurrence rates associated
with the disease (Castro-Córdova et al., 2021) and increases potential
to transmit C. difficile to other patients, even after diarrhoea has
resolved (Crobach et al., 2018). Indeed, 25–85% of all CDI
recurrences are attributed to the C. difficile strain that caused
initial infection (Oka et al., 2012). Our results are therefore very
promising with respect to the therapeutic potential of plantain
soluble dietary fibre and suggest that its use as a dietary
supplement could also help maintain remission from recurrent CDI.
As C. difficile and its toxins both interact with the intestinal
epithelium and possess lectin activity, we hypothesised that it was
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highly likely that soluble NSP from plantain could also inhibit the
action of C. difficile TcdA, TcdB and CDT on the intestinal
epithelium. Previous studies monitoring the mono-glucosylation
of Rho-GTPases have focussed on Rac1 due to the fact that its
inactivation has been deemed the main mechanism responsible
for the cytopathic effects of the C. difficile toxins TcdA and TcdB
(Popoff and Geny, 2011). TcdA and TcdB mediated Rac1 mono-
glucosylation has previously been investigated in HT29
colonocytes (Gerhard et al., 2008) through monitoring the
level of cellular Rac1 using anti-Rac1 102 antibody, which has
impaired recognition of Rac1 following its mono-glucosylation, at
Threonine position 35, giving an apparent decrease in Rac1 levels.
In our studies, we found that treatment of Caco-2 cells with
10 ng/ml C difficile TcdA or TcdB resulted in increased cellular
Rac1 mono-glucosylation, as measured by a decrease in anti-Rac1
102 antibody binding. We observed that intracellular TcdA and
TcdB mediated activity were both unaffected by pre-treatment
with soluble NSP from plantain. Other studies have provided
evidence of small molecules from natural sources with activity
against C. difficile (Tam et al., 2015; Pal and Seleem, 2020),
including some based on tea derivatives and flavonoids that
can directly reduce glucosylating C. difficile toxin-induced
cellular damage likely through blockade of glucosyltransferase
and hydrolase activity (Tam et al., 2015), highlighting the
important need to perhaps consider combination non-
antibiotic based therapies for treatment, and prophylactic
prevention, of CDI.
Other C. difficile toxin-mediated effects include the induction
of the pro-inflammatory response (Kim et al., 2006; Zemljic et al.,
2010), as well as the activation of apoptosis (Gerhard et al., 2008).
In our studies, treatment of Caco-2 cells with TcdA or TcdB
increased cellular IL-8 release (or KC, from mouse organoids)
and caspase-3 activation in a dose-dependent manner.
Interestingly, the cellular toxin response was slightly higher in
Caco-2 cells that were treated with TcdA. Indeed, there has been
great debate about the individual importance of TcdA and TcdB
during the course of clinical infection, and many conflicting
studies exist. Whilst our results are in agreement with studies
that suggest TcdA exhibits higher potency and cytotoxicity
in vitro (Poutanen and Simor, 2004; Kuehne et al., 2010),
others highlight that TcdB is the more potent toxin (Shen,
2012). In vivo animal experiments have also created debate
over the importance of TcdA and TcdB; whilst TcdA+, TcdB−
isogenic mutants used in a study by Keuhne and colleagues were
able to induce an in vivo pathogenic effect (Kuehne et al., 2010), in
a study by Lyras et al., the equivalent mutant strains were
observed to be avirulent (Lyras et al., 2009). TcdA−, TcdB+ C.
difficile strains are routinely isolated from CDI patients and are
capable of causing extensive disease (Voth and Ballard, 2005),
whilst very few TcdA+, TcdB− strains have been reported (Kuehne
et al., 2010). This suggests that both TcdA and TcdB likely play an
important role in the pathogenesis of CDI. Our results
demonstrate that whilst infection of Caco-2 cells with a
TcdA−, TcdB+ C. difficile strain does mount a considerable
cellular response, the response is much higher when cells are
treated with a TcdA+, TcdB+ C. difficile strain, suggesting that
they could in fact work together in synergy to produce an additive
effect. For CDT, we showed in our studies, that this binary toxin
was very potent in inducing pro-inflammatory IL-8 release from
human SW480 colonocytes and Intestine-407 cells.
Interestingly, our results indicate that plantain NSP reduces
the evoked cellular IL-8 response and caspase-3 activation in cells
treated either with purified TcdA, TcdB or CDT, as well as those
infected with toxin positive and toxin negative C. difficile strains.
Basal responses were also observed to be reduced in cell-lines pre-
treated with plantain NSP, suggesting that soluble dietary fibre,
and particularly its acidic components, may have a general
protective effect against the induction of a pro-inflammatory
response, cellular damage and apoptosis. As plantain NSP seems
to have no direct effect on toxin-mediated mono-glucosylation of
Rac1, rather it has a more general effect against the cellular
induction of the pro-inflammatory response and apoptosis, these
studies collectively indicate that plantain NSP does not inhibit the
specific intracellular activity of C. difficile toxins at intestinal
epithelial cells. Close proximity of C. difficile to the host
epithelium is almost certainly necessary for toxin release
(Sears and Kaper, 1996) and preventing these interactions
should therefore be of therapeutic benefit. With plantain NSP
preventing adhesion, and close apposition of, C. difficile to the
intestinal epithelium, we speculate that toxins would likely not be
released to any great extent, to be internalised by host cells.
5 CONCLUSION
In summary, plantain soluble non-starch polysaccharides possess
the ability to disrupt the epithelial interactions of C. difficile
vegetative cells and spores. This suggests that dietary
supplementation with plantain soluble fibre may confer a
protective effect in CDI patients by preventing bacterial
adhesion to the mucosa, i.e. a “contrabiotic” effect. More
specifically, plantain NSP blocks C. difficile adhesion, with
inhibitory activity against C. difficile found within the acidic
(pectin-rich) polysaccharide component, through interaction
with the intestinal epithelium. Further studies are required to
confirm the inhibitory epithelial mediated actions of plantain
NSP in further in vitromodels, and relevant in vivo models (Best
et al., 2012; Hutton et al., 2014; Pruss and Sonnenburg, 2021).
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